Crossmark

A multicenter, randomized controlled study on the efficacy of agomelatine in ameliorating anhedonia, reduced motivation, and circadian rhythm disruptions in patients with major depressive disorder (MDD)

Crossref DOI link: https://doi.org/10.1186/s12991-023-00473-y

Published Online: 2023-11-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Guo, Ping

Xu, Yong

Lv, Liang

Feng, Min

Fang, Yu

Huang, Wei-Quan

Cheng, Shan-Fei

Qian, Min-Cai

Yang, Shengliang

Wang, Shi-Kai

Chen, Huan-Xin
Funding

Funding for this research was provided by:

Science and Technology Project of Zhejiang Provincial (GF22H093655)

Nonprofit Applied Research Project of Huzhou Science and Technology Bureau (2017GY50, 2021GYB16)

Project of Huzhou the Third Hospital (2022SY2022112, 2022SY067)
License Information

Text and Data Mining valid from 2023-11-13

Version of Record valid from 2023-11-13
More Information

Article History

Received: 19 September 2023

Accepted: 13 October 2023

First Online: 13 November 2023

Declarations

:

: This study was conducted in accordance with the Declaration of Helsinki and approved by the Research Ethics Committee of Huzhou Third Municipal Hospital Affiliated to Huzhou University (ethical batch number: 2019LS028), and informed consent was obtained from all participants. All methods were carried out in accordance with relevant guidelines and regulations.

: All authors final approval of the version to be published.

: All of the authors had no any personal, financial, commercial, or academic conflicts of interest separately.

Document is current

Any future updates will be listed below